These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 709152)

  • 41. [Aminoglycoside nephropathy].
    Burchardt U; Schinköthe G; Meinel K; Anton D; Krebbel I; Neef L
    Z Gesamte Inn Med; 1982 Jun; 37(12):388-92. PubMed ID: 6750943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Conclusions of the symposium on ototoxicity of aminoglycosides].
    Conraux C
    Nouv Presse Med; 1978 Nov; 7(42):3859-60. PubMed ID: 714691
    [No Abstract]   [Full Text] [Related]  

  • 44. Nephrology Quiz and Questionnaire: 2009.
    Glassock RJ; Bargman JM; Palmer BF; Samaniego M; Fervenza FC
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1141-60. PubMed ID: 20498249
    [No Abstract]   [Full Text] [Related]  

  • 45. [The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Adv Clin Pharmacol; 1978; 15():69-90. PubMed ID: 676878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-sensitivity within the neomycin group of antibiotics.
    Förström L; Pirilä V; Pirilä L
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):67-9. PubMed ID: 160737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-Acetylcysteine in the prevention of ototoxicity.
    Tepel M
    Kidney Int; 2007 Aug; 72(3):231-2. PubMed ID: 17653228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Postoperative gentamycin therapy. Serum levels depending on dosage and temporary kidney dysfunction].
    Straube W; Tiesler E; Federspil P
    Med Klin; 1972 Jul; 67(27):941-5. PubMed ID: 5048691
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evaluation of the ototoxicity of aminoglycosides. Comparative study of dibekacin, gentamicin and tobramycin].
    Aran JM
    Nouv Presse Med; 1982 Nov; 11(46):3426-31. PubMed ID: 7155851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aminoglycoside-induced reversible tubular dysfunction.
    Alexandridis G; Liberopoulos E; Elisaf M
    Pharmacology; 2003 Mar; 67(3):118-20. PubMed ID: 12571406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reversible drug-induced uremia in chronic kidney diseases].
    Minetti L; De Min A; Grossi C; Torelli D
    Minerva Nefrol; 1976; 23(1):19-24. PubMed ID: 995327
    [No Abstract]   [Full Text] [Related]  

  • 53. Errors associated with applying decision support by suggesting default doses for aminoglycosides.
    Eslami S; Abu-Hanna A; de Keizer NF; de Jonge E
    Drug Saf; 2006; 29(9):803-9. PubMed ID: 16944965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-acetyl functions and acetate detected by nuclear magnetic resonance spectroscopy of urine to detect renal dysfunction following aminoglycoside and/or glycopeptide antibiotic therapy.
    Racine SX; Le Toumelin P; Adnet F; Cohen Y; Cupa M; Hantz E; Le Moyec L
    Nephron Physiol; 2004; 97(4):p53-7. PubMed ID: 15331932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low molecular weight proteins as urinary markers of aminoglycoside nephrotoxicity in man.
    Valette JP; Nicot G; Charmes JP; Merle L; Benevent D; Leroux-Robert C
    Proc Eur Dial Transplant Assoc; 1979; 16():597-602. PubMed ID: 95049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gram-negative bacillary meningitis therapy. Polyradiculitis following intralumbar aminoglycoside administration.
    Hollifield JW; Kaiser AB; McGee ZA
    JAMA; 1976 Sep; 236(11):1264-6. PubMed ID: 785039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical utility of a published nomogram to predict aminoglycoside nephrotoxicity.
    Lam YW; Arana CJ; Shikuma LR; Rotschafer JC
    JAMA; 1986 Feb; 255(5):639-42. PubMed ID: 3944964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].
    Ternhag A; Giske CG; Hanberger H
    Lakartidningen; 2014 Feb 12-18; 111(7):268-9. PubMed ID: 24669487
    [No Abstract]   [Full Text] [Related]  

  • 60. Pomegranate extract: a potential protector against aminoglycoside ototoxicity.
    Kahya V; Ozucer B; Dogan R; Meric A; Yuksel M; Gedikli O; Ozturan O
    J Laryngol Otol; 2014 Jan; 128(1):43-8. PubMed ID: 24451682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.